X0206 3 2025-02-01 0 0001831363 Terns Pharmaceuticals, Inc. TERN 0001799869 Strauss David Eric C/O TERNS PHARMACEUTICALS, INC. 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94014 false true false false Principal Accounting Officer Common Stock 89673.00 D Stock Option (Right to Buy) 17.00 2031-02-04 Common Stock 20000.00 D Stock Option (Right to Buy) 10.72 2031-09-27 Common Stock 11250.00 D Stock Option (Right to Buy) 10.43 2033-02-28 Common Stock 22500.00 D Stock Option (Right to Buy) 7.20 2034-03-14 Common Stock 33750.00 D Stock Option (Right to Buy) 6.59 2034-12-11 Common Stock 60000.00 D Includes 2,892 shares represented by a Restricted Stock Unit ("RSU"), of which 25% of the original 11,570 shares subject to the RSUs vested on the first anniversary measured from January 1, 2022 (the "Vesting Commencement Date"), and 1/16th of the total number of shares vested or will vest quarterly thereafter, such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date. Includes 15,750 shares represented by a Restricted Stock Unit ("RSU"), of which 25% of the original 31,500 shares subject to the RSUs vested on the first anniversary measured from January 1, 2023 (the "Vesting Commencement Date"), and 1/16th of the total number of shares vested or will vest quarterly thereafter, such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date. Includes 12,675 shares represented by a Restricted Stock Unit ("RSU"), of which 25% of the original 16,900 shares subject to the RSUs vested on the first anniversary measured from January 1, 2024 (the "Vesting Commencement Date"), and 1/16th of the total number of shares vested or will vest quarterly thereafter, such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date. 25% of the shares subject to the option vest on the first anniversary measured from January 25, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date. 25% of the shares subject to the option vest on the first anniversary measured from September 28, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date. 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date. 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date. 25% of the shares subject to the option vest on the first anniversary measured from December 12, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date. Exhibit 24.1 - Power of Attorney /s/ David Strauss 2025-02-11